Yildirim, M. E. Et Al. 2024. Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC. JOURNAL OF ONCOLOGY PHARMACY PRACTICE .

Yildirim, M. E., Karadurmus, N., Okten, I. N., TÜRK, H. M., Urakci, Z., Arslan, C., ... Celik, S.(2024). Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC. JOURNAL OF ONCOLOGY PHARMACY PRACTICE .

Yildirim, Mahmut Et Al. "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , 2024

Yildirim, Mahmut E. Et Al. "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , 2024

Yildirim, M. E. Et Al. (2024) . "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC." JOURNAL OF ONCOLOGY PHARMACY PRACTICE .

@article{article, author={Mahmut Emre Yildirim Et Al. }, title={Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2024}